文献速递外周动脉疾病

大动脉炎致髂动脉狭窄的腔内治疗:10年经验

Endovascular Treatment of Iliac Artery Stenosis Caused by Takayasu Arteritis: A 10-Year Experience.
PubMed 文献 · J Endovasc Ther · 2019-09-09

技术成功率为93.3%(28/30),平均随访4.8±3.3年,ABI、6分钟步行能力和Rutherford分级均显著改善,结论认为腔内治疗安全有效且长期临床结果良好。

要点

  • 腔内治疗TA相关髂动脉狭窄技术成功率高,长期症状改善明显。
  • 随访期间部分患者出现再狭窄或病变进展,需再次干预。
  • 严重并发症罕见,但需控制高血压等基础疾病。

核心结论

  • 腔内治疗对TA所致髂动脉狭窄安全有效,长期临床结果良好。

研究设计与样本

  • 所有患者均有跛行(Rutherford 2或3级),接受PTA和选择性支架植入。
  • 评估Rutherford分级、踝肱指数(ABI)、6分钟步行能力和不良事件。

主要发现

  • 腔内治疗髂动脉病变成功率为93.3%(28/30),1例双侧狭窄患者导丝未能通过病变。
  • 平均随访4.8±3.3年,18例无症状或仅有轻度间歇性跛行。
  • 4例出现中重度间歇性跛行(1例原病变进展,3例再狭窄),均再次行PTA。
  • 末次随访时ABI(0.95±0.12 vs 0.51±0.22,p<0.001)、6分钟步行能力(409.5±46.1 vs 272.6±32.3 m,p<0.001)和22例患者的Rutherford分级均改善。

临床怎么用

  • 对于TA所致髂动脉狭窄,可考虑PTA和选择性支架植入作为血运重建方式。
  • 术后需长期随访,监测再狭窄和病变进展,必要时再次干预。
  • 应积极控制高血压等基础疾病以降低并发症风险。

局限性

  • 单中心经验,结果可能受中心技术和患者选择影响。
  • 缺乏与药物治疗或其他血运重建方式的对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose: To evaluate the safety and efficacy of endovascular treatment for iliac artery stenosis caused by Takayasu arteritis (TA). Methods: Twenty-three consecutive TA patients (mean age 28.6±9.5 years; 17 women) with 30 iliac artery stenoses underwent percutaneous transluminal angioplasty (PTA) and selective stent implantation between January 2007 and December 2016. All had claudication (Rutherford category 2 or 3). The changes in the Rutherford category, ankle-brachial index (ABI), 6-minute walking capacity, and adverse events were assessed. Results: The success rate of endovascular therapy for iliac artery lesions was 93.3% (28/30). Guidewires could not cross either lesion in a patient with bilateral stenoses. Twenty-four lesions were treated by PTA alone and the other 4 lesions with provisional stents. One patient had a puncture site hematoma. Over an average of 4.8±3.3 years, 18 patients remained asymptomatic or had mild intermittent claudication. The other 4 patients developed moderate to severe intermittent claudication due to progression of a previously existing iliac lesion (n=1) or restenosis (n=3); all 4 underwent PTA. At the last follow-up, improvements were seen in the ABI (0.95±0.12 vs 0.51±0.22, p<0.001), 6-minute walking capacity (409.5±46.1 vs 272.6±32.3 m, p<0.001), and the Rutherford category of 22 patients. One patient died of a hemorrhagic stroke at 27 months due to uncontrolled hypertension. Conclusion: Endovascular therapy was safe and effective in treating TA patients with iliac artery stenosis, with good clinical outcomes in the long term.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Dong H, Chen Y, Xiong HL, et al. Endovascular Treatment of Iliac Artery Stenosis Caused by Takayasu Arteritis: A 10-Year Experience. J Endovasc Ther. 2019. PMID: 31496339. doi:10.1177/1526602819874474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。